Burnham C.-A. D., Carroll K. C. Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. // Clin. Microbiol. Rev. American Society for Microbiology, 2013. Vol. 26, № 3. P. 604-630.
Moon H.-W. et al. Comparison of diagnostic algorithms for detecting toxigenic Clostridium difficile in routine practice at a tertiary referral hospital in Korea // PLoS One. 2016. Vol. 11, № 8. P. e0161139.
Kachrimanidou M., Malisiovas N. Clostridium difficile Infection: A comprehensive review // Crit. Rev. Microbiol. 2011. Vol. 37, № 3. P. 178-187.
Collins D. А., Elliott B., Riley T. V. Molecular methods for detecting and typing of Clostridium difficile // Pathology. 2015. Vol. 47, № 3. P. 211-218.
Ananthakrishnan A. N., Issa M., Binion D. G. Clostridium difficile and inflammatory bowel disease // Med. Clin. North Am. Elsevier Ltd, 2010. Vol. 94, № 1. P. 135-153.
Binnicker M. J. Multiplex molecular panels for diagnosis of gastrointestinal infection: Performance, result interpretation, and cost-effectiveness // J. Clin. Microbiol. 2015. Vol. 53, № 12. P. 3723-3728.
Cunningham S. A. et al. Three-hour molecular detection of Campylobacter, Salmonella, Yersinia and Shigella species in feces with accuracy as high as that of culture // J. Clin. Microbiol. 2010. Vol. 48, № 8. P. 2929-2933.
Karre T. et al. Comparison of two commercial molecular assays to a laboratory-developed molecular assay for diagnosis of Clostridium difficile infection // J. Clin. Microbiol. 2011. Vol. 49, № 2. P. 725-727.
Buckwalter S. P. et al. Real-time qualitative PCR for 57 human adenovirus types from multiple specimen sources // J. Clin. Microbiol. 2012. Vol. 50, № 3. P. 766-771.
Buss S. N. et al. Multicenter evaluation of the BioFire FilmArray gastrointestinal panel for etiologic diagnosis of infectious gastroenteritis // J. Clin. Microbiol. 2015. Vol. 53, № 3. P. 915-925.
Kapusinszky B., Minor P., Delwart E. Nearly constant shedding of diverse enteric viruses by two healthy infants // J. Clin. Microbiol. 2012. Vol. 50, № 11. P. 3427-3434.
Mattila E. et al. A randomized, double-blind study comparing Clostridium difficile immune whey and metronidazole for recurrent Clostridium difficile-associated diarrhoea: Efficacy and safety data of a prematurely interrupted trial // Scand. J. Infect. Dis. Taylor & Francis, 2008. Vol. 40, № 9. P. 702-708.
Aguado J. M. et al. Highlighting clinical needs in Clostridium difficile infection: the views of European healthcare professionals at the front line. // J. Hosp. Infect. Elsevier, 2015. Vol. 90, № 2. P. 117-125.
Turgeon D. K. et al. Six Rapid Tests for direct detection of Clostridium difficile and its toxins in fecal samples compared with the fibroblast cytotoxicity assay // J. Clin. Microbiol. 2003. Vol. 41, № 2. P. 667-670.
Le R., Wallet G. F. Laboratory diagnosis of Clostridium difficile infection // Ann. Biol. Clin. Synthèse Ann Biol Clin. 2013. Vol. 71, № 714. P. 395-400.
Martin-Verstraete I., Peltier J., Dupuy B. The regulatory networks that control Clostridium difficile toxin synthesis // Toxins (Basel). 2016. Vol. 8, № 5. P. 1-24.
Bomers M. K. et al. Using a dog’s superior olfactory sensitivity to identify Clostridium difficile in stools and patients: proof of principle study // Bmj. 2012. Vol. 345, P. e7396.
Maurer M. et al. Detection of bacteriuria by canine olfaction // Open Forum Infect. Dis. 2016. Vol. 3, № 2. P. ofw051.
Novais R. C., Thorstenson Y. R. The evolution of Pyrosequencing?? for microbiology: From genes to genomes // J. Microbiol. Methods. Elsevier B. V., 2011. Vol. 86, № 1. P. 1-7.
Ley R. E., Peterson D. A., Gordon J. I. Ecological and evolutionary forces shaping microbial diversity in the human intestine // Cell. 2006. Vol. 124, № 4. P. 837-848.
Yoon S. S., Kim E. K., Lee W. J. Functional genomic and metagenomic approaches to understanding gut microbiota-animal mutualism // Curr. Opin. Microbiol. Elsevier Ltd, 2015. Vol. 24. P. 38-46.
Brown J. H. et al. Translating the human microbiome // Nat. Biotechnol. Nature Publishing Group, 2013. Vol. 31, № 4. P. 304-308.
Martín R. et al. The role of metagenomics in understanding the human microbiome in health and disease. // Virulence. 2014. Vol. 5, № 3. P. 413-423.
Kostic A. D., Xavier R. J., Gevers D. The Microbiome in iflammatory bowel diseases: current status and the future ahead // Gastroenterology. 2015. Vol. 146, № 6. P. 1489-1499.
Norman J. M. et al. Disease-specific Alterations in the enteric virome in inflammatory bowel disease // NIH Public Access. 2016. Vol. 160, № 3. P. 447-460.
Qin J. et al. A metagenome-wide association study of gut microbiota in type 2 diabetes // Nature. Nature Publishing Group, 2012. Vol. 490, № 7418. P. 55-60.
Karre T. et al. Comparison of two commercial molecular assays to a laboratory-developed molecular assay for diagnosis of Clostridium difficile infection // J. Clin. Microbiol. 2011. Vol. 49, № 2. P. 725-727.
Buckwalter S. P. et al. Real-time qualitative PCR for 57 human adenovirus types from multiple specimen sources // J. Clin. Microbiol. 2012. Vol. 50, № 3. P. 766-771.
Benedek O., Podbielski A., Warnke P. Laboratory experience with the liaison analyzer in the diagnosis of Clostridium difficile -associated diarrhea // Eur. J. Microbiol. Immunol. 2016. Vol. 6, № 3. P. 215-218.
Hassan S. A. et al. Hospital-acquired Clostridium difficile infection among patients with type 2 diabetes mellitus in acute medical wards // J. R. Coll. Physicians Edinb. 2013. Vol. 43, № 2. P. 103-107.
Martin J., Monaghan T., Wilcox M. H. Clostridium difficile infection: advances in epidemiology, diagnosis and understanding of transmission. // Nat. Rev. Gastro. Hep. Nature Publishing Group, 2016. Vol. In press.
A practical guidance document for the laboratory detection of toxigenic Clostridium difficile.-Washington, DC: American Society for Microbiology, 2010. -Режим доступа: http: // www.asm.org/images/pdf/Clinical/clostridiumdifficile9-21.pdf.